Related Experiment Video
Updated: Jun 12, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Treating an HIV-infected paediatric patient: an easy task?
Natella Y Rakhmanina1, John N van den Anker
1Division of Infectious Disease, Children's National Medical Center, Washington, DC, USA. nrakhman@cnmc.org
Insights
Simplified antiretroviral therapy regimens for children with HIV are evolving. Studies on pharmacokinetics and pharmacodynamics are crucial for developing age-appropriate dosing in pediatric populations.
Area of Science:
- Pediatric infectious diseases
- Pharmacology and pharmacotherapy
- HIV/AIDS treatment
Background:
- HIV-infected children are a diverse patient group, from neonates to young adults.
- Pediatric highly active antiretroviral therapy (HAART) transitions from liquid formulations to fixed-dose tablets.
- Simplified regimens can improve HAART implementation in children.
Purpose of the Study:
- To review the evolution of pediatric HAART.
- To highlight the need for age-specific dosing strategies.
- To emphasize the importance of pharmacokinetic and pharmacodynamic studies in pediatric HIV treatment.
Main Methods:
- Literature review on pediatric HAART evolution.
- Analysis of dosing regimen changes with age and maturity.
- Identification of research gaps in pediatric antiretroviral drug studies.
Main Results:
- Pediatric HAART has shifted towards simpler, once-daily fixed-dose tablet regimens.
- Dosing requirements change significantly from infancy through adolescence.
- Current research necessitates further pharmacokinetic and pharmacodynamic data for pediatric populations.
Conclusions:
- Simplified pediatric antiretroviral regimens enhance HAART adherence and effectiveness.
- Tailored pharmacokinetic and pharmacodynamic studies are essential for optimizing HIV treatment in infants, children, and adolescents.
- Further research is needed to establish precise dosing for diverse pediatric age groups.
Abstract:
HIV-infected children represent an incredibly diverse group of patients, ranging from neonates to young adults. With the change in age and maturity, paediatric highly active antiretroviral therapy (HAART) evolves from the meticulous twice-daily dosing of ml of liquid preparations to a choice of once-daily dosing of a single fixed-dose coformulated tablet. The use of simplified paediatric regimens could enhance the ability to achieve successful implementation of HAART in HIV-infected children. Pharmacokinetics and pharmacodynamic studies of antiretroviral drugs and their combinations need to be conducted in infants, children and adolescents to develop appropriate dosing in each of these specific groups.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Retrovirus Life Cycles
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Sexually Transmitted Infections

